219 related articles for article (PubMed ID: 36243282)
1. Current state of biologics in treating eosinophilic esophagitis.
Nhu QM; Aceves SS
Ann Allergy Asthma Immunol; 2023 Jan; 130(1):15-20. PubMed ID: 36243282
[TBL] [Abstract][Full Text] [Related]
2. Medical and dietary management of eosinophilic esophagitis.
Nhu QM; Aceves SS
Ann Allergy Asthma Immunol; 2018 Aug; 121(2):156-161. PubMed ID: 29753831
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic Esophagitis: the Potential Role of Biologics in its Treatment.
Choudhury S; Baker S
Clin Rev Allergy Immunol; 2020 Oct; 59(2):150-159. PubMed ID: 31175521
[TBL] [Abstract][Full Text] [Related]
4. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
Munoz-Persy M; Lucendo AJ
Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.
Hirano I; Dellon ES; Hamilton JD; Collins MH; Peterson K; Chehade M; Schoepfer AM; Safroneeva E; Rothenberg ME; Falk GW; Assouline-Dayan Y; Zhao Q; Chen Z; Swanson BN; Pirozzi G; Mannent L; Graham NMH; Akinlade B; Stahl N; Yancopoulos GD; Radin A
Gastroenterology; 2020 Jan; 158(1):111-122.e10. PubMed ID: 31593702
[TBL] [Abstract][Full Text] [Related]
6. New Developments in the Diagnosis and Treatment of Eosinophilic Esophagitis.
Nhu QM; Moawad FJ
Curr Treat Options Gastroenterol; 2019 Mar; 17(1):48-62. PubMed ID: 30707411
[TBL] [Abstract][Full Text] [Related]
7. Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?
Ko E; Chehade M
Clin Rev Allergy Immunol; 2018 Oct; 55(2):205-216. PubMed ID: 29372536
[TBL] [Abstract][Full Text] [Related]
8. Scientific journey to the first FDA-approved drug for eosinophilic esophagitis.
Rothenberg ME
J Allergy Clin Immunol; 2022 Dec; 150(6):1325-1332. PubMed ID: 36209816
[TBL] [Abstract][Full Text] [Related]
9. Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis.
Avlas S; Shani G; Rhone N; Itan M; Dolitzky A; Hazut I; Grisaru-Tal S; Gordon Y; Shoda T; Ballaban A; Ben-Baruch NM; Rochman M; Diesendruck Y; Nahary L; Bitton A; Halpern Z; Benhar I; Varol C; Rothenberg ME; Munitz A
Allergy; 2023 Feb; 78(2):464-476. PubMed ID: 36070083
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies.
Lucendo AJ
Expert Rev Clin Immunol; 2020 Jan; 16(1):63-77. PubMed ID: 31842634
[No Abstract] [Full Text] [Related]
11. Pathophysiology of eosinophilic esophagitis: recent advances and their clinical implications.
Ruffner MA; Kennedy K; Cianferoni A
Expert Rev Clin Immunol; 2019 Jan; 15(1):83-95. PubMed ID: 30394139
[No Abstract] [Full Text] [Related]
12. Eosinophilic esophagitis: current perspectives from diagnosis to management.
Moawad FJ; Cheng E; Schoepfer A; Al-Haddad S; Bellizzi AM; Dawson H; El-Zimaity H; Guindi M; Penagini R; Safrooneva E; Chehade M
Ann N Y Acad Sci; 2016 Sep; 1380(1):204-217. PubMed ID: 27467185
[TBL] [Abstract][Full Text] [Related]
13. Biologics in eosinophilic gastrointestinal diseases.
Dellon ES; Spergel JM
Ann Allergy Asthma Immunol; 2023 Jan; 130(1):21-27. PubMed ID: 35738437
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms.
Massironi S; Mulinacci G; Gallo C; Elvevi A; Danese S; Invernizzi P; Vespa E
Cells; 2023 Oct; 12(20):. PubMed ID: 37887317
[TBL] [Abstract][Full Text] [Related]
15. TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis.
Collison AM; Sokulsky LA; Sherrill JD; Nightingale S; Hatchwell L; Talley NJ; Walker MM; Rothenberg ME; Mattes J
J Allergy Clin Immunol; 2015 Oct; 136(4):971-82. PubMed ID: 25981737
[TBL] [Abstract][Full Text] [Related]
16. Management of Eosinophilic Esophagitis: Dietary and Nondietary Approaches.
Chen JW
Nutr Clin Pract; 2020 Oct; 35(5):835-847. PubMed ID: 32822071
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for eosinophilic esophagitis.
Pesek RD; Gupta SK
Expert Opin Emerg Drugs; 2018 Jun; 23(2):173-183. PubMed ID: 29848130
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review.
de Rooij WE; Dellon ES; Parker CE; Feagan BG; Jairath V; Ma C; Bredenoord AJ
Drugs; 2019 Sep; 79(13):1419-1434. PubMed ID: 31352605
[TBL] [Abstract][Full Text] [Related]
19. Current and emerging therapies for eosinophilic esophagitis.
Sher ER; Ross JA; Weine DM; Chandini Arjun A
Allergy Asthma Proc; 2022 May; 43(3):178-186. PubMed ID: 35524356
[No Abstract] [Full Text] [Related]
20. Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.
Schoepfer A; Safroneeva E; Straumann A
Dig Dis; 2016; 34(5):462-8. PubMed ID: 27333298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
